Cardiovascular

Cardiovascular disease affects millions of people around the world. Diseases commonly studied include coronary artery disease, myocardial infarction and renal impairment.

With decades of experience in cardiovascular drug discovery and development, Ricerca offers therapeutic expertise, as well as a complete list of validated cardiovascular-related in vivo models, using a broad panel of outcome measures. Our cardiovascular team includes directors with extensive industry experience who have authored numerous peer-reviewed cardiology published articles. All have deep experience in preclinical pharmacology and drug development, and many have served as principal scientists and section leaders at major pharmaceutical companies.

Our cardiovascular experts will tailor design models to your specific needs, ensuring solid science to support intended indications. We also provide additional endpoints, such as our trusted histology services, to help you meet the requirements for regulatory submission. Our team’s therapeutic expertise increases the reliability of results and helps clarify decision criteria for continued development.

Supporting services

• Histology

• Histopathology

• Biomarker – immunohistochemistry

• Screening and profiling assays

• ImmunoSignal™ – mediator release analysis

• OncoPanel™ – anti-cancer profiling and screening

• Early safety screening – cellular toxicity

• ADME/DMPK services